Rare diseases
Investigational molecules
Locations
Back to the Netherlands1 919 clinical trials in Leidschendam, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Long-Term Safety Study of BI 3720931 for Patients with Cystic Fibrosis from a Previous Trial
The NetherlandsStudy of Letetresgene Autoleucel for Patients with Synovial Sarcoma and Myxoid/Round Cell Liposarcoma
The NetherlandsStudy on the Safety and Effectiveness of BI 3720931 for Adults with Cystic Fibrosis Who Cannot Use CFTR Modulators
The NetherlandsStudy on the Effects and Safety of Riliprubart for Patients with Chronic Inflammatory Demyelinating Polyneuropathy Unresponsive to Usual Treatments
The NetherlandsStudy on Reduced Dose of Alteplase for Patients with Intermediate-High-Risk Acute Pulmonary Embolism
The NetherlandsStudy on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems
The NetherlandsStudy on the Effectiveness of Paclitaxel, Docetaxel, and Oxaliplatin in Patients with Resectable Gastric Cancer
The NetherlandsStudy on Long-term Safety of Seralutinib for Patients with Pulmonary Arterial Hypertension
The NetherlandsStudy Comparing Savolitinib and Durvalumab with Sunitinib and Durvalumab for Patients with Advanced Papillary Renal Cell Carcinoma
The NetherlandsStudy of Nivolumab and Relatlimab for Patients with Resectable Non-Small Cell Lung Cancer
The NetherlandsStudy on the Long-term Safety and Efficacy of Ralinepag for Patients with Pulmonary Arterial Hypertension
The NetherlandsStudy Comparing Ipilimumab and Nivolumab with Standard Nivolumab for Patients with Stage III Melanoma
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Multiple clinical trials focusing on non-small cell lung cancer (NSCLC) treatment advancements, evaluating novel therapeutic approaches including immunotherapy combinations and targeted treatments.
Studies compare various treatment options to improve patient outcomes and survival rates.
Comprehensive research into breast cancer treatments, particularly focusing on hormone receptor-positive and HER2-positive subtypes, investigating targeted therapies and chemotherapy combinations.
Trials examine innovative treatment strategies and personalized approaches.
Studies focusing on lymphoma treatments, including both Hodgkin and non-Hodgkin variants, evaluating response-adapted therapies and novel drug combinations.
Research aims to improve treatment outcomes while minimizing toxicity.
Investigations into colorectal cancer and related conditions, including innovative surgical approaches and treatment strategies for recurrent disease.
Focus on improving surgical outcomes and treatment effectiveness.
Studies examining treatment options for cerebral radiation necrosis and brain metastases, including innovative detection methods and therapeutic approaches.
Research aims to improve detection and treatment of brain metastases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
